BST.MC BME
Biotechnologies Assets S.A.
1W: -6.0%
1M: -11.7%
3M: -12.2%
YTD: -6.0%
1Y: -59.0%
3Y: -56.9%
5Y: -57.8%
€0.19 ($0.21)
+0.00 (+1.06%)
Weekly Expected Move ±5.8%
€0
€0
€0
€0
€0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$74K
-254.7% ▼
Capital Expenditures
$721K
-121.1% ▼
5Y CAGR: -37.4%
Free Cash Flow
-$795K
-185.6% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$121K
-58.4% ▼
Net Change in Cash
-$157K
+53.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$3M | -$204M | $2M | -$3M |
| Depreciation & Amort. | $2M | $2M | $215M | $2M | $2M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $12M | -$496K | -$15M | -$477K | -$323K |
| Other Non-Cash Items | $3M | -$23K | $3M | -$4M | $1M |
| Operating Cash Flow | $9M | -$2M | -$2M | $48K | -$74K |
| — Investing Activities — | |||||
| Capital Expenditures | -$392K | -$661K | -$212M | -$70K | -$14K |
| Acquisitions (Net) | -$609K | $0 | $0 | $0 | $0 |
| Investment Purchases | $387K | $0 | $0 | $0 | $0 |
| Investment Sales | $999K | $0 | $0 | $0 | $0 |
| Other Investing | $44M | $0 | $0 | -$256K | -$707K |
| Investing Cash Flow | $45M | -$661K | -$212M | -$326K | -$721K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$58M | $240K | $670 | -$79 | -$87K |
| Stock Repurchased | -$15K | $0 | -$8M | -$76K | -$121K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $70K | $3M | -$284K | -$496K | -$54K |
| Financing Cash Flow | -$58M | $3M | $115M | -$61K | $638K |
| Net Change in Cash | -$4M | $1M | -$99M | -$339K | -$157K |
| Cash End of Period | $556K | $2M | $69M | $353K | $196K |
| Free Cash Flow | $8M | -$2M | -$213M | -$278K | -$795K |